RISK FACTORS FOR THE DEVELOPMENT OF MDR-TUBERCULOSIS AND MEASURES FOR ITS PREVENTION
PDF

Keywords

Multidrug-resistant tuberculosis, risk factors, drug resistance, Mycobacterium tuberculosis, prevention, early diagnosis, treatment adherence, epidemiological surveillance.

How to Cite

Batirova Barçinoy Tadjimuxammadovna. (2026). RISK FACTORS FOR THE DEVELOPMENT OF MDR-TUBERCULOSIS AND MEASURES FOR ITS PREVENTION. GREAT BRITAIN - SCIENTIFIC REVIEW OF THE PROBLEMS AND PROSPECTS OF MODERN SCIENCE AND EDUCATION, 1(20), 45-51. https://e-conferences.org/index.php/GB/article/view/1704

Abstract

This article examines the major risk factors contributing to the development of multidrug-resistant tuberculosis (MDR-TB) and evaluates effective measures for its prevention. Particular attention is paid to the clinical, epidemiological, socioeconomic, and behavioral determinants associated with the emergence and spread of drug-resistant Mycobacterium tuberculosis strains. The study analyzes the influence of previous tuberculosis treatment, inappropriate use of anti-tuberculosis medications, interruption of treatment, poor patient adherence to prescribed therapeutic regimens, delayed diagnosis, and contact with individuals infected with drug-resistant tuberculosis. Furthermore, the article explores the importance of modern molecular diagnostic technologies, drug susceptibility testing, appropriate treatment strategies, epidemiological surveillance, and infection prevention and control measures. Special emphasis is placed on improving access to quality-assured medicines, strengthening healthcare services, providing social and psychological support to patients, and increasing public awareness of tuberculosis prevention. The findings highlight that multidimensional and coordinated preventive interventions are essential for reducing the development and transmission of MDR-TB. The article concludes that early diagnosis, rational treatment, continuous patient monitoring, and effective public health policies constitute fundamental elements in combating multidrug-resistant tuberculosis and improving treatment outcomes.

PDF